$MFON
Mobivity Holdings Corp

2023 Q2 Form 10-Q Financial Statement

#000143774923014552 Filed on May 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $1.861M $1.881M $2.030M
YoY Change -0.32% -7.3% -17.42%
Cost Of Revenue $1.371M $1.067M $1.175M
YoY Change 14.01% -9.22% 12.78%
Gross Profit $490.0K $814.9K $854.6K
YoY Change -26.26% -4.65% -39.64%
Gross Profit Margin 26.33% 43.31% 42.11%
Selling, General & Admin $1.674M $2.235M $1.805M
YoY Change 14.33% 23.86% -17.45%
% of Gross Profit 341.67% 274.3% 211.17%
Research & Development $804.3K $734.4K $702.2K
YoY Change -7.95% 4.58% -3.0%
% of Gross Profit 164.16% 90.12% 82.17%
Depreciation & Amortization $56.50K $63.90K $124.3K
YoY Change -51.66% -48.6% -12.2%
% of Gross Profit 11.53% 7.84% 14.55%
Operating Expenses $2.515M $3.034M $2.631M
YoY Change 2.72% 15.29% -14.48%
Operating Profit -$2.025M -$2.219M -$1.777M
YoY Change 13.5% 24.89% 6.97%
Interest Expense $244.4K $238.4K $159.8K
YoY Change 46.26% 49.19% 391.53%
% of Operating Profit
Other Income/Expense, Net -$247.1K -$259.5K -$156.5K
YoY Change 47.38% 65.79% 374.48%
Pretax Income -$2.272M -$2.478M -$1.933M
YoY Change 16.41% 28.2% 14.13%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.272M -$2.478M -$1.900M
YoY Change 13.6% 30.43% 12.18%
Net Earnings / Revenue -122.08% -131.71% -93.62%
Basic Earnings Per Share -$0.03 -$0.04 -$0.03
Diluted Earnings Per Share -$0.03 -$0.04 -$33.78K
COMMON SHARES
Basic Shares Outstanding 65.80M 65.61M 58.57M
Diluted Shares Outstanding 65.67M shares 62.08M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $529.5K $2.582M $1.455M
YoY Change -51.49% 77.41% 41.66%
Cash & Equivalents $529.5K $2.582M $1.455M
Short-Term Investments
Other Short-Term Assets $423.4K $212.9K $333.2K
YoY Change 19.7% -36.09% -2.67%
Inventory
Prepaid Expenses
Receivables $542.7K $750.0K $491.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.496M $3.545M $2.279M
YoY Change -34.21% 55.51% -41.52%
LONG-TERM ASSETS
Property, Plant & Equipment $878.4K $930.7K $1.132M
YoY Change -18.77% -17.81% 0.0%
Goodwill $0.00 $0.00 $411.2K
YoY Change -100.0% -100.0% -17.16%
Intangibles $99.26K $143.9K $1.016M
YoY Change -89.07% -85.84% -20.36%
Long-Term Investments
YoY Change
Other Assets $127.4K $142.5K $157.4K
YoY Change -17.03% -9.47% -50.0%
Total Long-Term Assets $1.105M $1.217M $2.717M
YoY Change -56.73% -55.2% -38.24%
TOTAL ASSETS
Total Short-Term Assets $1.496M $3.545M $2.279M
Total Long-Term Assets $1.105M $1.217M $2.717M
Total Assets $2.601M $4.762M $4.996M
YoY Change -46.13% -4.69% -39.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.482M $3.336M $3.503M
YoY Change -3.41% -4.78% 56.14%
Accrued Expenses $1.004M $1.195M $835.6K
YoY Change 16.36% 43.03% 32.39%
Deferred Revenue $469.8K $704.7K
YoY Change 55.04%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.379M $1.352M $1.521M
YoY Change 12.8% -11.12% 251.83%
Total Short-Term Liabilities $6.349M $6.603M $6.033M
YoY Change 5.95% 9.44% 34.74%
LONG-TERM LIABILITIES
Long-Term Debt $3.653M $3.926M $1.919M
YoY Change 36.17% 104.62% 28.72%
Other Long-Term Liabilities $801.5K $870.1K $1.128M
YoY Change -24.75% -22.84% -45.22%
Total Long-Term Liabilities $4.726M $4.796M $3.047M
YoY Change 26.11% 57.44% -14.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.349M $6.603M $6.033M
Total Long-Term Liabilities $4.726M $4.796M $3.047M
Total Liabilities $11.08M $11.40M $9.080M
YoY Change 13.71% 25.55% 13.12%
SHAREHOLDERS EQUITY
Retained Earnings -$122.6M -$120.4M -$109.8M
YoY Change 9.74% 9.69% 8.39%
Common Stock $113.9M $65.61K $58.60K
YoY Change 190869.05% 11.96% 5.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.475M -$6.638M -$4.084M
YoY Change
Total Liabilities & Shareholders Equity $2.601M $4.762M $4.996M
YoY Change -46.13% -4.69% -39.78%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.272M -$2.478M -$1.900M
YoY Change 13.6% 30.43% 12.18%
Depreciation, Depletion And Amortization $56.50K $63.90K $124.3K
YoY Change -51.66% -48.6% -12.2%
Cash From Operating Activities -$2.043M -$1.443M -$1.800M
YoY Change 19.78% -19.81% -5.36%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $14.11K $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$14.11K $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.710K $3.578M 2.544M
YoY Change -100.5% 40.61% -1250.92%
NET CHANGE
Cash From Operating Activities -2.043M -$1.443M -1.800M
Cash From Investing Activities 0.000 -$14.11K 0.000
Cash From Financing Activities -6.710K $3.578M 2.544M
Net Change In Cash -2.050M $2.155M 719.7K
YoY Change 450.46% 199.4% -131.91%
FREE CASH FLOW
Cash From Operating Activities -$2.043M -$1.443M -$1.800M
Capital Expenditures $0.00 $14.11K $0.00
Free Cash Flow -$2.043M -$1.458M -$1.800M
YoY Change 20.28% -19.02% -8.99%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001447380
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
MOBIVITY HOLDINGS CORP.
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10820 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34446 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65607411
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61311155
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65607411
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61311155
CY2022Q4 us-gaap Goodwill
Goodwill
0 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-53851
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3439095
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3133 West Frye Road, # 215
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chandler
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85226
CY2023Q1 dei City Area Code
CityAreaCode
877
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
282-7660
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
65797567
CY2023Q1 us-gaap Cash
Cash
2581597 usd
CY2022Q4 us-gaap Cash
Cash
426740 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
749986 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1081183 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
212939 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
195017 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3544522 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1702940 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
930658 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
981896 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
143857 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
194772 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
142464 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
137917 usd
CY2023Q1 us-gaap Assets
Assets
4761501 usd
CY2022Q4 us-gaap Assets
Assets
3017525 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
3335917 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3412612 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
442269 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
443448 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
495209 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
569347 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
704740 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
902727 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
257614 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
251665 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15462 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
49541 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6602830 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8373128 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
870057 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
936924 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4796385 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
3449306 usd
CY2023Q1 us-gaap Liabilities
Liabilities
11399215 usd
CY2022Q4 us-gaap Liabilities
Liabilities
11822434 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
65607 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
61311 usd
CY2023Q1 mfon Equity Amount Payable
EquityAmountPayable
317086 usd
CY2022Q4 mfon Equity Amount Payable
EquityAmountPayable
324799 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
113423638 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108806353 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-69461 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100963 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120374584 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117896409 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-6637714 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8804909 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4761501 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3017525 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1881482 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2029569 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
1066575 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
1174948 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
814907 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
854621 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1544106 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1207176 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
691220 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
597501 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
734375 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
702223 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
63902 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
124312 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3033603 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2631212 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2218696 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1776591 usd
CY2023Q1 mfon Gains Losses On Settlement Of Debt
GainsLossesOnSettlementOfDebt
-10857 usd
CY2022Q1 mfon Gains Losses On Settlement Of Debt
GainsLossesOnSettlementOfDebt
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
238446 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
159827 usd
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-10000 usd
CY2022Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-176 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3319 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-259479 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-156508 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2478175 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1933099 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2478175 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1933099 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
31502 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12895 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2446673 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1945994 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62078218
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57233309
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-5284181 usd
CY2022Q1 mfon Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
2550553 usd
CY2022Q1 mfon Adjustments To Additional Paid In Capital Fair Value Of Options Issued With Related Party Debt
AdjustmentsToAdditionalPaidInCapitalFairValueOfOptionsIssuedWithRelatedPartyDebt
6201 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
589650 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-12895 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1933099 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-4083771 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-8804909 usd
CY2023Q1 mfon Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
3587487 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
216223 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
810157 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
31502 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2478175 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-6637714 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2478175 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1933099 usd
CY2023Q1 mfon Gain Loss On Settlement Of Debt
GainLossOnSettlementOfDebt
-10857 usd
CY2022Q1 mfon Gain Loss On Settlement Of Debt
GainLossOnSettlementOfDebt
-0 usd
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-10576 usd
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-10705 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
810157 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
589650 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63902 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124312 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
31567 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24205 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-341773 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-98004 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
17891 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
105749 usd
CY2023Q1 mfon Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
-9680 usd
CY2022Q1 mfon Increase Decrease In Operating Lease Assets And Liabilities
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilities
2822 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3423 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-76695 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-320445 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
204188 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
133125 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-77402 usd
CY2022Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-203103 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-34079 usd
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 usd
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-9071 usd
CY2023Q1 mfon Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
-197987 usd
CY2022Q1 mfon Increase Decrease In Deferred Revenue And Customer Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerDeposits
-203791 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1443464 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1813845 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14111 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14111 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
9978 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
6354 usd
CY2023Q1 mfon Proceeds From Conversion Of Common Stock Warrants
ProceedsFromConversionOfCommonStockWarrants
3587487 usd
CY2022Q1 mfon Proceeds From Conversion Of Common Stock Warrants
ProceedsFromConversionOfCommonStockWarrants
2550553 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3577509 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2544199 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34923 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10631 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2154857 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
719723 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
426740 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
735424 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2581597 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1455147 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 mfon Fair Value Of Options Issued With Related Party Debt
FairValueOfOptionsIssuedWithRelatedPartyDebt
0 usd
CY2022Q1 mfon Fair Value Of Options Issued With Related Party Debt
FairValueOfOptionsIssuedWithRelatedPartyDebt
6201 usd
CY2023Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">1.</em> Nature of Operations and Basis of Presentation</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Mobivity Holdings Corp. (the “Company” or “we”) is in the business of developing and operating proprietary platforms over which brands and enterprises can conduct national and localized, data-driven mobile marketing campaigns. Our proprietary platforms, consisting of software available to phones, tablets, PCs, and Point of Sale (“POS”) systems, allow resellers, brands, and enterprises to market their products and services to consumers through text messages sent directly to consumers via mobile phones, mobile smartphone applications, and dynamically printed receipt content. On <em style="font: inherit;"> November </em><em style="font: inherit;">14,</em> <em style="font: inherit;">2018,</em> we completed the acquisition of certain operating assets relating to Belly, Inc.’s proprietary digital customer loyalty platform, including client contracts, accounts receivable, and intellectual property. We generate revenue by charging the resellers, brands, and enterprises a per-message transactional fee, through fixed or variable software licensing fees, or via advertising fees.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form <em style="font: inherit;">10</em>-Q and Rule <em style="font: inherit;">8</em>-<em style="font: inherit;">03</em> of Regulation S-<em style="font: inherit;">X</em> promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do <em style="font: inherit;">not</em> include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form <em style="font: inherit;">10</em>-K for the year ended <em style="font: inherit;"> December 31, 2022</em>filed with the SEC on <em style="font: inherit;"> March </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of <em style="font: inherit;"> March 31, 2023</em>, and for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023 </em>and <em style="font: inherit;">2022</em>. The results of operations for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023</em> are <em style="font: inherit;">not</em> necessarily indicative of the operating results for the full year ending <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2023.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results <em style="font: inherit;"> may </em>differ from these estimates.</p>
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><i>Reclassifications</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did <em style="font: inherit;">not</em> affect previously reported net losses.</p>
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10820 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34446 usd
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
963659 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2446673 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1945994 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
54248 usd
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
163734 usd
CY2023Q1 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
2581597 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2478175 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1443464 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1933099 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1813845 usd
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3600000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120400000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
91438 usd
CY2023Q1 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
-0 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8970 usd
CY2023Q1 mfon Fx And Other Of Intangible Assets
FxAndOtherOfIntangibleAssets
3 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
82468 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8970 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
38888 usd
CY2022Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
103334 usd
CY2023Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 usd
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
41945 usd
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
61389 usd
CY2023Q1 mfon Operating Lease Right Of Use Asset Current
OperatingLeaseRightOfUseAssetCurrent
0 usd
CY2023Q1 mfon Operating Lease Right Of Use Asset Noncurrent
OperatingLeaseRightOfUseAssetNoncurrent
930658 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
930658 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
257614 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
870057 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1127671 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
243583 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
330894 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
337568 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
344241 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
28733 usd
CY2023Q1 mfon Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
0 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1285019 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
157348 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1127671 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M29D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0675 pure
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
5277947 usd
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
5256170 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1351619 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2743788 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3926328 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2512382 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
238446 usd
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
159827 usd
CY2022Q1 mfon Number Of Warrant Holders That Exercised Warrants
NumberOfWarrantHoldersThatExercisedWarrants
17 pure
CY2022Q1 mfon Stock Issued During Period Shares Warrant Exercise
StockIssuedDuringPeriodSharesWarrantExercise
3188190
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.80
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1062500
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.80
CY2022Q2 mfon Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
850000 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1500000
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.80
CY2022Q3 mfon Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
1200000 usd
CY2023Q1 mfon Equity Amount Payable
EquityAmountPayable
317086 usd
CY2022Q1 mfon Number Of Employees Awards Granted
NumberOfEmployeesAwardsGranted
1 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.8289
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P36M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.54
CY2022Q1 mfon Sharebased Compensation Arrangement By Sharebased Payment Award Call Option Value
SharebasedCompensationArrangementBySharebasedPaymentAwardCallOptionValue
81035 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
45000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.97
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P36M
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.642608
CY2022Q2 mfon Sharebased Compensation Arrangement By Sharebased Payment Award Call Option Value
SharebasedCompensationArrangementBySharebasedPaymentAwardCallOptionValue
28917 usd
CY2022Q3 mfon Number Of Employees Awards Granted
NumberOfEmployeesAwardsGranted
1 pure
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1000000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.98
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P36M
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
0.697499
CY2022Q3 mfon Sharebased Compensation Arrangement By Sharebased Payment Award Call Option Value
SharebasedCompensationArrangementBySharebasedPaymentAwardCallOptionValue
697499 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0247 pure
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7233 pure
CY2022Q1 mfon Number Of Warrant Holders That Exercised Warrants
NumberOfWarrantHoldersThatExercisedWarrants
17 pure
CY2022Q1 mfon Stock Issued During Period Shares Warrant Exercise
StockIssuedDuringPeriodSharesWarrantExercise
3188190
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.80
CY2022Q1 mfon Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
2550553 usd
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
177571
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
73469 usd
CY2023Q1 us-gaap Loss Contingency Claims Settled Number
LossContingencyClaimsSettledNumber
3 pure
CY2023Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-10000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
mfon-20230331_cal.xml Edgar Link unprocessable
0001437749-23-014552-index-headers.html Edgar Link pending
0001437749-23-014552-index.html Edgar Link pending
0001437749-23-014552.txt Edgar Link pending
0001437749-23-014552-xbrl.zip Edgar Link pending
ex_497192.htm Edgar Link pending
ex_497193.htm Edgar Link pending
ex_497194.htm Edgar Link pending
ex_517959.htm Edgar Link pending
ex_517973.htm Edgar Link pending
ex_517978.htm Edgar Link pending
ex_517983.htm Edgar Link pending
ex_519136.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mfon-20230331.xsd Edgar Link pending
mobv20230331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
mfon-20230331_def.xml Edgar Link unprocessable
mfon-20230331_lab.xml Edgar Link unprocessable
mfon-20230331_pre.xml Edgar Link unprocessable
mobv20230331_10q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending